New research claims honeybee venom can inhibit growth of cancer cells
Category: #health  By Nikita Chaurasia  Date: 2020-09-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

New research claims honeybee venom can inhibit growth of cancer cells

According to a recent study published in NPJ Precision Oncology journal by Harry Perkins Institute of Medical Research, honeybee venom is capable of rapidly destroying HER2-enriched breast cancer cells and triple-negative breast cancer in the human body.

Sources close to the matter claimed that the Perth-based institute tested the effect of the venom on mice subjects and discovered that it acts as an efficient anti-tumor agent which can disrupt the growth of an aggressive form of breast cancer, with minimal damage to the existing normal cells.

For the record, triple-negative breast cancer, that accounts for 10-15% of all breast cancers, is a type of disease that lacks the three most common cancer-drug receptors, namely progesterone, estrogen, and the human epidermal growth factor known as HER2.

As per credible sources, the research team found out that a synthetic equivalent of melittin, a peptide present in honeybee venom, mirrored the anti-tumor effects of the venom and suppressed the growth of the cells of HER2-enriched breast cancer as well as triple-negative breast cancer.

It is to be noted that Melittin, when introduced to the affected regions, enters the plasma membrane and forms pores, which causes the cancer cells to die. The peptide combined with chemotherapy drugs such as docetaxel, punctures the cancer membrane, thereby allowing better entry for chemo into the cancerous mass, sources claimed.

Ciara Duffy, a researcher who led the study, was reported stating that her team observed the peptide and the venom was causing interference in the main cancer-signaling pathways that are primarily responsible for the replication and growth of the cancer cells.

In other news, a UK-based study has recently been published to investigate the impact of COVID-19 on cancer patients. The project CCP (Clinical Characterisation Protocol) will reportedly address the concerns associated with care for patients with cancer amidst COVID-19 pandemic.

Source credits: https://nypost.com/2020/09/01/honeybee-venom-can-kill-aggressive-breast-cancer-cells-study/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Ransomware attack cripples IT systems of United Health Services Inc.
Ransomware attack cripples IT systems of United Health Services Inc.
By Nikita Chaurasia

  The company claims that no patient records were compromised. UHS system files were being renamed with the addition of a ‘.ryk’ extension. Universal Health Services Inc. (UHS), U.S.-based leading healthcare service provider w...

New research claims sufficiency of vitamin D reduces COVID-19 severity
New research claims sufficiency of vitamin D reduces COVID-19 severity
By Nikita Chaurasia

According to a recent study, COVID-19 patients having sufficient levels of vitamin D, with at least 30 ng/mL of 25-hydroxyvitamin D in their blood, are less likely to witness severe clinical outcomes and deaths. The study, which was published by the...

Amazon adds indoor surveillance drone to security solutions portfolio
Amazon adds indoor surveillance drone to security solutions portfolio
By Nikita Chaurasia

  This is the next big launch after the announcement of car security devices Indoor drone will offer video surveillance in places devoid of static cameras U.S.-based multinational technology giant, Amazon.com Inc. along with Ring Inc. has ...